These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23797455)

  • 1. [Initial experience with the use of cardioverter-defibrillator leads with DF-4 connector in the resynchronisation therapy].
    Maciąg A; Sterliński M; Zając D; Szwed H
    Kardiol Pol; 2013; 71(6):665-6. PubMed ID: 23797455
    [No Abstract]   [Full Text] [Related]  

  • 2. Wearable cardioverter-defibrillator as a bridge to implantable cardioverter-defibrillator treatment.
    Technol Eval Cent Assess Program Exec Summ; 2010 Nov; 25(2):1-5. PubMed ID: 21638938
    [No Abstract]   [Full Text] [Related]  

  • 3. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
    Proclemer A; Ghidina M
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
    [No Abstract]   [Full Text] [Related]  

  • 4. An Extrapericardial Minimally Invasive Approach for Implantable Cardioverter Defibrillator.
    Madjarov JM; Katz MG; Poole B; Madzharov S; Fedor JM; Robicsek F
    Thorac Cardiovasc Surg; 2017 Sep; 65(6):475-478. PubMed ID: 28324909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantation of additional defibrillation lead into the coronary sinus: an effective method of decreasing defibrillation threshold.
    Wilczek R; Swiątkowski M; Czepiel A; Sterliński M; Makowska E; Kułakowski P
    Kardiol Pol; 2011; 69(12):1308-9. PubMed ID: 22219117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inappropriate shock from a subcutaneous implantable cardioverter-defibrillator due to transcutaneous electrical nerve stimulation.
    Miller MA; Palaniswamy C; Sharma D; Reddy VY
    Heart Rhythm; 2015 Jul; 12(7):1702-3. PubMed ID: 25889810
    [No Abstract]   [Full Text] [Related]  

  • 7. Beyond the implantable cardioverter-defibrillator: are we making progress?
    Weiss JN
    Heart Rhythm; 2008 Jun; 5(6 Suppl):S45-7. PubMed ID: 18456201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automatic implantable defibrillator for the patient with recurrent refractory malignant ventricular arrhythmias: case report.
    Stack JM; Houston C; Mirowski M; Mower M; Watkins L; Reid PR
    Heart Lung; 1982; 11(6):512-5. PubMed ID: 6922850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seventh try's a charm: ventricular fibrillation terminated by the seventh shock.
    Li J; Zitron E; Katus HA; Becker R
    Circ Arrhythm Electrophysiol; 2011 Apr; 4(2):e4-6. PubMed ID: 21505170
    [No Abstract]   [Full Text] [Related]  

  • 10. Developing a crush: acute implantable cardioverter-defibrillator lead insulation break in a patient with multiple leads.
    Tilling L; Mason M
    Europace; 2014 Aug; 16(8):1196. PubMed ID: 25074973
    [No Abstract]   [Full Text] [Related]  

  • 11. Initial clinical experience with endocardial defibrillation using an implantable cardioverter/defibrillator with a triple-electrode system.
    Saksena S; Tullo NG; Krol RB; Mauro AM
    Arch Intern Med; 1989 Oct; 149(10):2333-9. PubMed ID: 2802898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New approach to implantable cardioverter-defibrillators in small pediatric patients: dorsal positioning of superior vena cava shock lead in a 3-year-old.
    Pedersen SB; Smerup MH; Nielsen JC
    J Thorac Cardiovasc Surg; 2014 Jul; 148(1):358-60. PubMed ID: 24685380
    [No Abstract]   [Full Text] [Related]  

  • 13. Automatic implantable cardioverter defibrillator: a new treatment modality for recurrent ventricular tachycardia and ventricular fibrillation.
    Singer I; Rademaker M; Slater D; Kupersmith J
    J Ky Med Assoc; 1988 Jun; 86(6):289-92. PubMed ID: 3385314
    [No Abstract]   [Full Text] [Related]  

  • 14. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation.
    Kuck KH
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):713-20; discussion 720. PubMed ID: 20009082
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical evaluation of a dual chamber implantable cardioverter-defibrillator].
    Kazmierczak J; Tavernier R; De Sutter J; Jordaens L
    Pol Merkur Lekarski; 2000 Aug; 9(50):522-6. PubMed ID: 11081315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
    Wilkoff BL; Fauchier L; Stiles MK; Morillo CA; Al-Khatib SM; Almendral J; Aguinaga L; Berger RD; Cuesta A; Daubert JP; Dubner S; Ellenbogen KA; Mark Estes NA; Fenelon G; Garcia FC; Gasparini M; Haines DE; Healey JS; Hurtwitz JL; Keegan R; Kolb C; Kuck KH; Marinskis G; Martinelli M; McGuire M; Molina LG; Okumura K; Proclemer A; Russo AM; Singh JP; Swerdlow CD; Teo WS; Uribe W; Viskin S; Wang CC; Zhang S
    Heart Rhythm; 2016 Feb; 13(2):e50-86. PubMed ID: 26607062
    [No Abstract]   [Full Text] [Related]  

  • 17. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy and safety of implantable cardioverter defibrillator avoiding routine defibrillation threshold testing].
    Liu Q; Zhou S; Qi S; Zeng G; Ma X; Huang H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Nov; 34(11):1132-5. PubMed ID: 19952404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indications for implantable cardioverter-defibrillator].
    Tebbenjohanns J; Niehaus M; Korte T
    Dtsch Med Wochenschr; 2002 Oct; 127(41):2120-4. PubMed ID: 12397558
    [No Abstract]   [Full Text] [Related]  

  • 20. Out of the guidelines: should an intracardiac defibrillator be implanted in patients with recurrent early ventricular fibrillation due to recurrent acute myocardial infarction?
    Faggiano P; Pulcini E; Curnis A; Vizzardi E; Cas LD
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):371-3. PubMed ID: 17443105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.